Definitive Contract HT942525C0010
Award Date
2/5/25
Potential Completion Date
6/4/27
Potential Value
$1.3M
Federal Agency
Defense Health Agency
Awardee
Emergingdx Inc.
Ultimate Awardee
Not listed
NAICS Category
541715 - Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
Federal Contract Vehicle
Set-Aside Type
Total Small Business
Extent Competed
Full and Open Competition after exclusion of sources
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Lowell, MA 01852, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
2
Legislative Mandate
Employment Eligibility Verification
National Interest Action
Not listed
Research Type
STTR Phase II
Primary Consortia Member
Not listed
Similar Awards
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a for-profit subchapter S corporation based in Mansfield, Massachusetts. The $249,998.68 firm-fixed-price contract is for the development of a "Multiplexed Diagnostic Platform for Invasive Fungal Infection." Emergingdx is a company focused on developing diagnostic and biosensor technologies, with an emphasis on disease detection and precision medicine...
This federal contract award is for a Small Business Innovation Research (SBIR) Phase I project from the Defense Health Agency (DHA) to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract, valued at $249,993.61, supports the development of a "Rapid, Automated, Multiplexed Omics Platform" for medical research and diagnostic applications. As a total small business set-aside contract, this award demonstrates Emergingdx Inc.'s expertise...
This STTR Phase I contract, valued at $246,350.00, was awarded by the Office of Naval Research (ONR), a defense agency, to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is set aside for small businesses. Emergingdx Inc. specializes in developing advanced diagnostic and biosensor technologies for disease detection and precision medicine applications, with a focus on early disease detection, biomarker analysis, and rapid diagnostic...
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Health Agency (DHA) to Emergingdx Inc., a small business based in Mansfield, Massachusetts. The contract, valued at $1,299,988.98, supports the development of an automated detection platform for circulating and exosomal microRNAs. This research and development effort is focused on medical diagnostics and aligns with the DHA's mission to advance healthcare technologies. The contract was awarded on...
The Defense Health Agency (DHA) awarded a $249,837.63 Small Business Technology Transfer (STTR) Phase I contract to Emergingdx Inc., a small business subchapter S corporation based in Mansfield, Massachusetts. The contract is for the development of an automated detection platform for circulating and exosomal microRNAs, with potential applications in early disease detection and precision medicine. This contract is part of the DHA's research and development efforts in advanced diagnostic and...
This is a $999,923 Small Business Innovation Research (SBIR) Phase II contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Inflammatix, Inc., a small disadvantaged business in Sunnyvale, California. The contract is for the development of point-of-care diagnostic solutions to monitor the host-pathogen interaction during infection. Inflammatix has been awarded over $29 million in federal contracts and grants from agencies like the Department of Health and Human Services and...
This is a Small Business Innovation Research (SBIR) Phase I contract awarded by the Defense Health Agency (DHA) to Firebird Biomolecular Sciences LLC, a for-profit limited liability company, for the development of "Innovative DNA for Highly Multiplexed Molecular Diagnostics". The $249,956.88 firm-fixed-price contract has a period of performance ending on May 8, 2025. The contract supports research and development of novel molecular technologies to create a rapid, point-of-sampling...
<p>The U.S. Air Force Research Laboratory (AFRL) awarded a Small Business Innovation Research (SBIR) Phase II contract worth $1,249,994.00 to Dxlab Inc., a for-profit organization, for the development of a portable and rugged infection diagnostic platform that provides rapid, clinically actionable pathogen detection at deployed locations and military treatment facilities. The contract has a total small business set-aside designation and is set to be completed by December 8, 2025.</p>
This is a Small Business Innovation Research (SBIR) Phase II contract awarded by the Department of the Army Materiel Command to Dxdiscovery Inc., a for-profit Subchapter S corporation, to conduct research and development efforts. The total award amount is $999,995.10, and the contract has a firm fixed price pricing type. The contract was awarded on December 20, 2017, with a completion date of February 13, 2020. The contract is set aside for total small business participation, and the potential...
This is a Firm Fixed Price contract awarded by the Defense Advanced Research Projects Agency (DARPA) to Probiusdx Inc., a small business, under the Small Business Innovation Research (SBIR) Program Phase I. The contract is for the development of point-of-care technologies to monitor and characterize host-pathogen interactions during acute severe infection. The contract has a ceiling value of $147,130.17 and an ultimate completion date of November 24, 2017. The contract is set aside for small...